RACHEL GRACI: Open Payments
NPI 1891273827 · NIAGARA FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 27 payments from 15 companies in 2025. Trend: 2023 $931 · 2024 $892 · 2025 $767
Food & beverage: $689Education: $78
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $206 |
| SEAGEN INC. | 1 | $78 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| BeOne Medicines USA, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Celgene Corporation | 2 | $41 |
| Aveo Pharmaceuticals, Inc. | 1 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
| ABBVIE INC. | 1 | $29 |
Products named: ERLEADA, RYBREVANT, KISQALI, OJJAARA, REBLOZYL, FOTIVDA, TALVEY, Onivyde.
Industry payments across NY — which companies pay providers there.
